Evaluation of tamarind seed polysaccharide (TSP) as a mucoadhesive and sustained release component of nifedipine buccoadhesive tablet & comparison with HPMC and Na CMC

International Journal of PharmTech Research

Volumn 1, Issue 3, 2009, Pages 404-410

  Patel, Bhavin ^a   Patel, Piyush ^a   Bhosale, Ashok ^a   Hardikar, Shrawaree ^a   Mutha, Swati ^a   Chaulang, Ganesh ^a  

^a S G R S College of Pharmacy   (India)

Author keywords

Bioadhesive Strength; Buccal mucoadhesive tablet; In vitro retention time; Nifedipine; Tamarind seed polysaccharide

Indexed keywords

CARBOMER; CARBOXYMETHYLCELLULOSE; HYDROXYPROPYLMETHYLCELLULOSE; NIFEDIPINE; POLYMER; POLYSACCHARIDE;

ANIMAL TISSUE; ARTICLE; CHEEK MUCOSA; CONTROLLED STUDY; DRUG FORMULATION; DRUG RETENTION; FIRST PASS EFFECT; GOAT; HYDRATION; IN VITRO STUDY; MUCOADHESION; NANOFABRICATION; NONHUMAN; PH; PHYSICAL CHEMISTRY; PLANT SEED; SUSTAINED DRUG RELEASE; TABLET FORMULATION; TAMARIND;

EID: 77953428820     PISSN: None     EISSN: 09744304     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. Chowdary KR, Ramesh KS, Controlled nifedipine release from microcapsules of its dispersions in PVP-MCC and HPC-MCC. Drug Dev. Ind. Pharm, 1995, 21: 1183-1192.
2. Murdock D, Brogden RN, Sustained release nifedipine formulations. Drugs, 1991, 41:737-779.
3. Benet LZ, ∅ie S, Schwartz JB, Design and optimization of dosage regimens; pharmacokinetic data, in: J.G. Hardman, A. Goodman Gilman, L.E. Limbird (Eds.), Goodman and Gilman's The Pharmacological Basis of Therapeutics, 9th ed, McGraw-Hill, New York, 1996, 1675.
4. Longer MA, Ch'ng HS, Robinson JR, Bioadhesive polymers as platforms for oral controlled drug delivery. J. Pharm. Sci, 74:406-411.
5. PDR (Physicians' Desk Reference), 54th ed., Medical Economics Company Inc, Montvale, NJ, 2000 pp. 331, 673, 2363.
6. Kohri N, Mori KI, Miyazaki K, Arita T, Sustained release of nifedipine from granules. J. Pharm. Sci, 1986, 75:57-61.
7. Barkai A, Pathak YV, Benita S, Polyacrylate (Eudragit retard) microspheres for oral controlled release of nifedipine. Drug Dev. Ind. Pharm, 1990, 16:2057-2075.
8. Maggi L, Torre ML, Giunchedi P, Conte U, Supramicellar solutions of sodium dodecyl sulphate as dissolution media to study in vitro release characteristics of sustained release formulations containing an insoluble drug: nifedipine. Int. J. Pharm, 1996, 135:73-79.
9. Chickering DE, Mathiowitz E, Definitions, mechanisms, and theories of bioadhesion, in: E. Mathiowitz, D.E. Chickering, C.M. Lehr, C.M. Lehr (Eds.), Bioadhesive Drug Delivery Systems, Fundamentals, Novel Approaches, and Development, Marcel Dekker Inc., New York, 1999, 1.
10. Ahuja A, Khar RK, Ali J, Mucoadhesive drug delivery systems. Drug Dev. Ind. Pharm, 1997, 23:489-515.
11. Morimoto K, Tabata H, Morisaka K, Nasal absorption of nifedipine from gel preparation in rats. Chem. Pharm. Bull, 1987, 35:3041- 3044.
12. Save T, Venkitachalam P, Buccoadhesive tablets of nifedipine: standardization of a novel buccoadhesive erodible carrier. Drug Dev. Ind. Pharm, 1994, 20:3005-3014.
13. Burgalassi S, Panichi L, Saettone MF, Jacobsen J, Rassing MR, Development and in vitro/in vivo testing of mucoadhesive buccal patches releasing benzylamine and lidocaine. Int. J. Pharm, 1996, 133:1-7.
14. Prudat-Christiaens C, Arnaud P, Allain P, Chaumeil JC, Aminophylline bioadhesive tablets attempted by wet granulation. Int. J. Pharm, 1996, 141:109-116.
15. Nandi RC, A Process for preparation of polyose from the seeds of Tamarindus indica, Ind. Pat, 142092, 1975.
16. Rao PS, Srivastav HC, Tamarind. In Indusrtial Gums, (Ed.) R.L. Whistler, Academic Press, 2nd Ed, New York, 1973, 369-411.
17. Rao PS, Extraction and purification of tamarind seed polysaccharide. J Sci Ind Research, 1946, 4:705.
18. Gupta A, Garg S, Khar RK, Interpolymer complexation and its effect on bioadhesive strength and dissolution characteristics of buccal drug delivery systems. Drug Dev Ind Pharm, 1994, 20:315-325.
19. Parodi B, Russo E, Caviglioli G, Cafaggi S, Bigbardi G, Development and characterization of a buccoadhesive dosage form of oxycodane hydrochloride. Drug Dev Ind Pharm, 1996, 22:445-450.